Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices

Align Technology Inc. (ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a competitor's complaint, scrutinizing whether Align has violated antitrust laws through its practices related to its flagship Invisalign clear aligners and iTero intraoral scanners. Central to the investigation is the allegation that Align has engaged in anti-competitive practices by tying the use of its Invisalign products to its proprietary iTero scanners, a claim that if substantiated, could have serious implications for the company’s market strategy and its competitive practices within the dental medical devices industry.

European Commission Probes Align's Market Practices

The European Commission's investigation focuses on the interoperability of Align’s products. Since 2017, there have been claims that Align has denied approval for competing scanning devices and dismissed scans from rival devices that are compliant with industry standards. This examination raises concerns about whether Align is effectively creating a closed ecosystem that limits competition while reinforcing its dominance in the clear aligner market. By possibly restricting access to its iTero scanners for third-party products, Align may be fortifying its market share at the expense of competitors and potentially hindering innovation within the sector.

Align Technology's Response

In response to the initiated investigation, Align Technology firmly disputes the allegations of misconduct. The company asserts that its business practices focus on quality, innovation, and customer experience rather than unfair competitive advantages. Align maintains that its iTero platform plays a vital role in a broader digital dental ecosystem, supporting scans for various aligner brands, which contrasts with the narrative of anti-competitive behavior. With over 24 million scans completed using iTero since 2018, Align claims its practices promote a collaborative approach within the dental community.

Corporate Integrity Under Scrutiny

As the investigation unfolds, Align expresses confidence that its compliance with global competition laws will be evident and views the proceedings as procedural, assuring stakeholders of its commitment to legal conduct and corporate integrity.